Affiliation:
1. Department of Urology, The Central Hospital of Wuhan, Wuhan, P.R. China
Abstract
Transforming acidic coiled-coil protein 3 (TACC3) is a member of the TACC family and plays an important role in regulating cell mitosis, transcription, and tumorigenesis. However, the expression pattern and roles of TACC3 in renal cell carcinoma (RCC) remain unclear. The aim of this
study was to investigate the role of TACC3 in RCC. We demonstrated overexpression of TACC3 in human RCC cell lines at both RNA and protein levels. Moreover, knockdown of TACC3 repressed RCC cell proliferation, migration, and invasion in vitro. In addition, knockdown of TACC3 inactivated PI3K/Akt
signaling in RCC cells. Furthermore, knockdown of TACC3 significantly reduced tumor growth in xenograft tumor-bearing mice. Taken together, our findings showed that TACC3 was increased in human RCC cell lines, and knockdown of TACC3 inhibited the ability of cell proliferation, migration, invasion, and tumorigenesis in vivo. Therefore, TACC3 may act as a therapeutic target for the treatment of human RCC.
Subject
Cancer Research,Oncology,General Medicine
Reference29 articles.
1. Renal cell carcinoma guideline;Actas Urol Esp.,2009
2. Renal cell carcinoma: Treatment options;Br J Nurs.,2011
3. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Ann Oncol.,2012
4. Treatment of metastatic renal cell carcinoma;Cancer Chemother Pharm.,2009
5. Renal cell carcinoma: Current status and future prospects;Cancer Treat Rev.,2005
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献